Identification of Covariates Modulating B‐Cell Repopulation Kinetics in Subjects Receiving Rituximab Treatment.

Objective: B‐cell depletion using the anti‐CD20 monoclonal antibody rituximab is a cornerstone in the therapeutic concept of multiple autoimmune diseases. B‐cell depletion is associated with a higher risk for severe infections, and the time span of B‐cell repopulation differs greatly between individ...

Full description

Bibliographic Details
Published in:Arthritis & Rheumatology Vol. 75; no. 11; pp. 2045 - 2054
Main Authors: Welte, Thomas, Westermann, Lukas, Kappes, Julia, Schramm, Markus A., Bemtgen, Xavier, Staudacher, Dawid L., Hug, Martin J., Venhoff, Nils, Arnold, Frederic
Format: research tables/charts Journal Article
Published: Wiley-Blackwell Nov2023
Online Access:View this record in EBSCOhost